ArticleMedicine2026
Pulmonary sclerosing pneumocytoma masquerading as lung metastasis: A case report.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
rationalePulmonary sclerosing pneumocytoma (PSP) is a rare benign neoplasm primarily affecting middle-aged Asian women. Although typically presenting as a well-circumscribed solitary nodule with an indolent clinical course, PSP can occasionally exhibit aggressive radiological features. In patients with a history of malignancy, these atypical findings can lead to a significant diagnostic dilemma, frequently mimicking metastatic disease. PATIENT CONCERNS: A 42-year-old female with a history of breast cancer was referred for evaluation of a lung nodule identified during surveillance. Contrast-enhanced chest computed tomography (CT) revealed a 1.6-cm juxtapleural mass in the right middle lobe. Notably, the lesion showed apparent vessel abutment and suspected vascular invasion, leading to a presumptive radiological diagnosis of angioinvasive metastasis. F-fluorodeoxyglucose positron emission tomography/CT demonstrated low F-fluorodeoxyglucose uptake with a maximum standardized uptake value of 1.6. DIAGNOSES: Despite the preoperative suspicion of malignancy based on aggressive CT features, the diagnosis of PSP was confirmed through histopathological examination following surgical intervention.
interventionsThe patient underwent an open wedge resection. Intraoperative findings revealed a well-demarcated mass without inflammatory adhesions or pericardial involvement. OUTCOMES: The postoperative course was uneventful, and no recurrence was observed during the follow-up period. LESSONS: This case highlights that PSP can radiologically masquerade as angioinvasive metastasis, especially in oncological patients. Clinicians and radiologists should consider PSP as a differential diagnosis for solitary pulmonary nodules with suspected vascular invasion, even when positron emission tomography/CT shows low metabolic activity. Histopathological confirmation remains the gold standard for avoiding overdiagnosis and unnecessary radical treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.